Other factors include a family history of cutaneous and uveal melanoma, dysplastic nevus syndrome, ocular or oculodermal melanocytosis—namely Nevus of Ota—and mutation of breast cancer 1 (BRCA1) associated protein 1 (BAP1) [3,6,9,10,11,12,13,14,15,16]. This evidence concerns the gene BAP1 and nevus of Ota.